WallStSmart

The Cooper Companies, Inc (COO)vsIntuitive Surgical Inc (ISRG)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Intuitive Surgical Inc generates 161% more annual revenue ($11.03B vs $4.23B). ISRG leads profitability with a 28.4% profit margin vs 5.6%. COO appears more attractively valued with a PEG of 0.69. ISRG earns a higher WallStSmart Score of 66/100 (B-).

COO

Buy

59

out of 100

Grade: C

Growth: 6.7Profit: 3.5Value: 6.7Quality: 7.0
Piotroski: 4/9Altman Z: 2.65

ISRG

Strong Buy

66

out of 100

Grade: B-

Growth: 8.0Profit: 9.0Value: 6.0Quality: 7.8
Piotroski: 4/9Altman Z: 5.95
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

COOUndervalued (+59.9%)

Margin of Safety

+59.9%

Fair Value

$206.89

Current Price

$74.23

$132.66 discount

UndervaluedFair: $206.89Overvalued
ISRGUndervalued (+80.5%)

Margin of Safety

+80.5%

Fair Value

$1922.89

Current Price

$373.71

$1549.18 discount

UndervaluedFair: $1922.89Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

COO4 strengths · Avg: 8.3/10
Debt/EquityHealth
0.309/10

Conservative balance sheet, low leverage

PEG RatioValuation
0.698/10

Growing faster than its price suggests

Price/BookValuation
1.8x8/10

Reasonable price relative to book value

EPS GrowthGrowth
26.9%8/10

Earnings expanding 26.9% YoY

ISRG6 strengths · Avg: 9.0/10
Operating MarginProfitability
33.6%10/10

Strong operational efficiency at 33.6%

Altman Z-ScoreHealth
5.9510/10

Safe zone — low bankruptcy risk

Market CapQuality
$131.94B9/10

Large-cap with strong market position

Profit MarginProfitability
28.4%9/10

Keeps 28 of every $100 in revenue as profit

Revenue GrowthGrowth
18.5%8/10

18.5% revenue growth

EPS GrowthGrowth
26.5%8/10

Earnings expanding 26.5% YoY

Areas to Watch

COO4 concerns · Avg: 2.3/10
Return on EquityProfitability
2.9%3/10

ROE of 2.9% — below average capital efficiency

Profit MarginProfitability
5.6%3/10

5.6% margin — thin

P/E RatioValuation
61.3x2/10

Premium valuation, high expectations priced in

Operating MarginProfitability
-2.9%1/10

Operating margin of -2.9%

ISRG2 concerns · Avg: 4.0/10
PEG RatioValuation
1.734/10

Expensive relative to growth rate

P/E RatioValuation
39.7x4/10

Premium valuation, high expectations priced in

Comparative Analysis Report

WallStSmart Research

Bull Case : COO

The strongest argument for COO centers on Debt/Equity, PEG Ratio, Price/Book. PEG of 0.69 suggests the stock is reasonably priced for its growth.

Bull Case : ISRG

The strongest argument for ISRG centers on Operating Margin, Altman Z-Score, Market Cap. Profitability is solid with margins at 28.4% and operating margin at 33.6%. Revenue growth of 18.5% demonstrates continued momentum.

Bear Case : COO

The primary concerns for COO are Return on Equity, Profit Margin, P/E Ratio. A P/E of 61.3x leaves little room for execution misses.

Bear Case : ISRG

The primary concerns for ISRG are PEG Ratio, P/E Ratio.

Key Dynamics to Monitor

COO profiles as a value stock while ISRG is a growth play — different risk/reward profiles.

ISRG carries more volatility with a beta of 1.46 — expect wider price swings.

ISRG is growing revenue faster at 18.5% — sustainability is the question.

ISRG generates stronger free cash flow (948M), providing more financial flexibility.

Bottom Line

ISRG scores higher overall (66/100 vs 59/100), backed by strong 28.4% margins and 18.5% revenue growth. COO offers better value entry with a 59.9% margin of safety. Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

The Cooper Companies, Inc

HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA

The Cooper Companies, Inc., branded as CooperCompanies, is a global medical device company headquartered in San Ramon, California.

Visit Website →

Intuitive Surgical Inc

HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA

Intuitive Surgical, Inc. is an American corporation that develops, manufactures, and markets robotic products designed to improve clinical outcomes of patients through minimally invasive surgery, most notably with the da Vinci Surgical System.

Want to dig deeper into these stocks?